Vir Biotechnology Inc (VIR)
7.11
+0.16
(+2.30%)
USD |
NASDAQ |
Nov 22, 10:41
Vir Biotechnology Shareholders Equity (Quarterly): 1.241B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.241B |
| June 30, 2024 | 1.434B |
| March 31, 2024 | 1.547B |
| December 31, 2023 | 1.590B |
| September 30, 2023 | 1.675B |
| June 30, 2023 | 1.810B |
| March 31, 2023 | 1.971B |
| December 31, 2022 | 2.078B |
| September 30, 2022 | 2.150B |
| June 30, 2022 | 1.952B |
| March 31, 2022 | 2.001B |
| December 31, 2021 | 1.432B |
| Date | Value |
|---|---|
| September 30, 2021 | 876.27M |
| June 30, 2021 | 737.32M |
| March 31, 2021 | 650.95M |
| December 31, 2020 | 716.85M |
| September 30, 2020 | 812.36M |
| June 30, 2020 | 563.78M |
| March 31, 2020 | 380.33M |
| December 31, 2019 | 423.94M |
| September 30, 2019 | -280.80M |
| June 30, 2019 | 401.45M |
| December 31, 2018 | -179.18M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
380.33M
Minimum
Mar 2020
2.150B
Maximum
Sep 2022
1.302B
Average
1.433B
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc | 92.29B |
| Biomarin Pharmaceutical Inc | 5.413B |
| Arbutus Biopharma Corp | 106.89M |
| GlycoMimetics Inc | 11.38M |
| FibroGen Inc | -243.67M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.498B |
| Total Liabilities (Quarterly) | 257.63M |
| Current Ratio | 8.938 |